1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
---------------------------------
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): OCTOBER 3, 2001
MONSANTO COMPANY
------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
DELAWARE 001-16167 43-1878297
------------------------------------------------------------------------------------------------
(State or Other Jurisdiction of (Commission File Number) (IRS Employer Identification No.)
Incorporation)
800 NORTH LINDBERGH BOULEVARD
ST. LOUIS, MISSOURI 63167
------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code: (314) 694-1000
2
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS.
(c) Exhibits
99 Slide presentation prepared for use by Chief Financial Officer
of Monsanto Company on October 3, 2001 at the Credit Suisse
First Boston 2001 Chemical Industry Conference and at a
separate presentation to financial analysts.
ITEM 9. REGULATION FD DISCLOSURE
On October 3, 2001, Monsanto Company's Chief Financial Officer will
speak at the Credit Suisse First Boston 2001 Chemical Industry Conference and
will also participate in a presentation to financial analysts. A slide
presentation given at both the conference and financial analysts presentation
is attached to this report as Exhibit 99 and incorporated herein by reference.
We are furnishing the information contained in this report, including
the attached slide presentation, pursuant to Regulation FD promulgated by the
Securities and Exchange Commission ("SEC"). This information is furnished
pursuant to Item 9 of Form 8-K and shall not be deemed to be "filed" for the
purposes of Section 18 of the Securities Exchange Act of 1934 or otherwise
subject to the liabilities of that section, unless we specifically incorporate
it by reference in a document filed under the Securities Act of 1933 or the
Securities Exchange Act of 1934. By filing this report on Form 8-K and
furnishing this information, we make no admission as to the materiality of any
information in this report that is required to be disclosed solely by reason of
Regulation FD or that the information includes material investor information
that is not otherwise publicly available.
The information contained in this report, including the information
contained in the attached slide presentation, is summary information that is
intended to be considered in the context of our SEC filings and other public
announcements that we may make, by press release or otherwise, from time to
time. We disclaim any current intention to revise or update the information
contained in this report, including the information contained in the attached
slide presentation, although we may do so from time to time as our management
believes is warranted. Any such updating may be made through the filing of other
reports or documents with the SEC, through press releases or through other
public disclosure.
A copy of the attached slide presentation is available for viewing on
our website located at http:\\www.monsanto.com, although we reserve the right to
discontinue that availability at any time. The attached slide presentation can
be accessed from the website by first clicking on "Investors" at the top of the
home page and then clicking on "Presentations" on the left menu bar on the
Investors page.
2
3
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
Dated: October 3, 2001
MONSANTO COMPANY
By: /s/ Michael L. DeCamp
----------------------------------------
Name: Michael L. DeCamp
Assistant General Counsel and
Assistant Secretary
3
4
EXHIBIT INDEX
Exhibit
Number Description
99 Slide presentation prepared for use by Chief Financial Officer
of Monsanto Company on October 3, 2001 at the Credit Suisse
First Boston 2001 Chemical Industry Conference and at a
separate presentation to financial analysts.
4